Latest filing published 01 Mar 2022 for X4 Pharmaceuticals, Inc.
Filing timeline
BuySaleInsider track record
No signal scores available.
Diego Cadavid: trading record in brief
Diego Cadavid, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Fulcrum Therapeutics, Inc. and X4 Pharmaceuticals, Inc. Between 12 May 2020 and 1 March 2022, the trades on record add up to 21 filings.
The open-market record consists of 11 sales worth €118k, with no purchase. The amount is not disclosed for 1 filing. Outside the open market, there are 1 share grant and 9 option exercises. Since January 2022: no purchases and 1 sale on the market.
On 1 March 2022 came the latest disclosure, a share grant in X4 Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Diego Cadavid
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 97,000 shares0Common StockSEC:0001628280-22-004495:0
- 928 sharesCommon StockSEC:0001628280-22-002505:0
- 1,071 shares@ US$18.30Common StockSEC:0000899243-20-018278:0
- 1,459 shares@ US$4.83Common StockSEC:0000899243-20-017761:0
- 1,459 shares@ US$22.00Common StockSEC:0000899243-20-017761:1
- 401 shares@ US$4.83Common StockSEC:0000899243-20-016382:0
- 401 shares@ US$22.00Common StockSEC:0000899243-20-016382:1
- 226 shares@ US$4.83Common StockSEC:0000899243-20-015623:0
- 226 shares@ US$20.05Common StockSEC:0000899243-20-015623:1
- 451 shares@ US$4.83Common StockSEC:0000899243-20-015623:2
- 451 shares@ US$20.18Common StockSEC:0000899243-20-015623:3
- 45 shares@ US$4.83Common StockSEC:0000899243-20-015245:0
- 45 shares@ US$20.00Common StockSEC:0000899243-20-015245:1
- 338 shares@ US$4.83Common StockSEC:0000899243-20-015245:2
- 338 shares@ US$20.18Common StockSEC:0000899243-20-015245:3
- 600 shares@ US$4.83Common StockSEC:0000899243-20-014722:0
- 600 shares@ US$20.00Common StockSEC:0000899243-20-014722:1
- 200 shares@ US$4.83Common StockSEC:0000899243-20-014722:2
- 200 shares@ US$20.04Common StockSEC:0000899243-20-014722:3
- 1,860 shares@ US$4.83Common StockSEC:0000899243-20-012822:0
- 1,860 shares@ US$18.00Common StockSEC:0000899243-20-012822:1
21 of 21 declarations
